These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23330927)

  • 1. Polyphenols: a diverse class of multi-target anti-HIV-1 agents.
    Andrae-Marobela K; Ghislain FW; Okatch H; Majinda RR
    Curr Drug Metab; 2013 May; 14(4):392-413. PubMed ID: 23330927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.
    Salehi B; Kumar NVA; Şener B; Sharifi-Rad M; Kılıç M; Mahady GB; Vlaisavljevic S; Iriti M; Kobarfard F; Setzer WN; Ayatollahi SA; Ata A; Sharifi-Rad J
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency viral replication by tannins and related compounds.
    Nakashima H; Murakami T; Yamamoto N; Sakagami H; Tanuma S; Hatano T; Yoshida T; Okuda T
    Antiviral Res; 1992 May; 18(1):91-103. PubMed ID: 1416904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in natural products-based anti-AIDS research.
    Yu D; Morris-Natschke SL; Lee KH
    Med Res Rev; 2007 Jan; 27(1):108-32. PubMed ID: 16888749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trilobatin as an HIV-1 entry inhibitor targeting the HIV-1 Gp41 envelope.
    Yin S; Zhang X; Lai F; Liang T; Wen J; Lin W; Qiu J; Liu S; Li L
    FEBS Lett; 2018 Jul; 592(13):2361-2377. PubMed ID: 29802645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the study of anti-HIV natural compounds derived from traditional Chinese medicines].
    Zhang X; Huang N; Zheng YT
    Yao Xue Xue Bao; 2010 Feb; 45(2):141-53. PubMed ID: 21351425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets.
    Kang D; Song Y; Chen W; Zhan P; Liu X
    Mol Biosyst; 2014 Aug; 10(8):1998-2022. PubMed ID: 24841339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents.
    Wang HK; Xia Y; Yang ZY; Natschke SL; Lee KH
    Adv Exp Med Biol; 1998; 439():191-225. PubMed ID: 9781305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C; Bailly F; Cotelle P
    Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?
    Garbelli A; Riva V; Crespan E; Maga G
    Biochem J; 2017 Apr; 474(10):1559-1577. PubMed ID: 28446620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional medicines, HIV, and related infections: workshop 2C.
    Patel M; Bessong P; Liu H
    Adv Dent Res; 2011 Apr; 23(1):159-64. PubMed ID: 21441498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting strategies for Human immunodeficiency virus: a combinatorial approach.
    Saxena SK; Gupta A; Bhagyashree K; Saxena R; Arora N; Banerjee AK; Tripathi AK; Chandrasekar MJ; Gandhi N; Nair MP
    Mini Rev Med Chem; 2012 Mar; 12(3):236-54. PubMed ID: 22356194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally derived anti-HIV agents.
    Asres K; Seyoum A; Veeresham C; Bucar F; Gibbons S
    Phytother Res; 2005 Jul; 19(7):557-81. PubMed ID: 16161055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy.
    Flores A; Quesada E
    Curr Med Chem; 2013 Feb; 20(6):751-71. PubMed ID: 23278399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection - an update (1998 - 2007).
    Cos P; Maes L; Vlietinck A; Pieters L
    Planta Med; 2008 Sep; 74(11):1323-37. PubMed ID: 18671200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent agents containing 1-substituted 2,3,4-trihydroxyphenyl moieties as novel synthetic polyphenols directed against HIV-1.
    Flores A; Camarasa MJ; Pérez-Pérez MJ; San-Félix A; Balzarini J; Quesada E
    Org Biomol Chem; 2014 Jul; 12(28):5278-94. PubMed ID: 24927059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV drug development--an overview.
    Pereira CF; Paridaen JT
    Curr Pharm Des; 2004; 10(32):4005-37. PubMed ID: 15579085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activities and possible dental application of three major groups of polyphenols.
    Sakagami H
    J Pharmacol Sci; 2014; 126(2):92-106. PubMed ID: 25263279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of flavonoids: A diverse group of natural compounds with anti-Candida albicans activity in vitro.
    Seleem D; Pardi V; Murata RM
    Arch Oral Biol; 2017 Apr; 76():76-83. PubMed ID: 27659902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.